 MesotheliomaHelp.org (blog) |
'Unprecedented' Disease Control in Mesothelioma Trial
Medscape PHILADELPHIA — Mesothelioma can be added to the list of cancers that respond to immunotherapy with programmed-death (PD) inhibitors, said one researcher in response to early results showing good disease control with pembrolizumab (Keytruda, … Merck's Drug Keytruda Shows 'Encouraging' Results in Mesothelioma Clinical Trial |
SOURCE: Mesothelioma – Google News – Read entire story here.
Related posts:
Mesothelioma Patients Often Deal With Blood Clots – MesotheliomaHelp.org (blog)
Study Suggests Skin Cancer Drug May Help Treat Mesothelioma and Lung … – The National Law Review
Orange County Motorcycle Accident Proves Fatal
Powerful Skin Cancer Drug Stops Mesothelioma Tumor Growth – Asbestos.com
